                         SEQUENCE LISTING

<110>  Hla, Timothy
       Obinata, Hideru
       Galvani, Sylvain
       Dahlback, Bjorn
       Nielsen, Lars Bo
       Christoffersen, Christina
       Blaho, Victoria
 
<120>  Endothelium Protective Materials and Methods of Use

<130>  27646

<150>  61/489,045
<151>  2011-05-23

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  188
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Phe His Gln Ile Trp Ala Ala Leu Leu Tyr Phe Tyr Gly Ile Ile 
1               5                   10                  15      


Leu Asn Ser Ile Tyr Gln Cys Pro Glu His Ser Gln Leu Thr Thr Leu 
            20                  25                  30          


Gly Val Asp Gly Lys Glu Phe Pro Glu Val His Leu Gly Gln Trp Tyr 
        35                  40                  45              


Phe Ile Ala Gly Ala Ala Pro Thr Lys Glu Glu Leu Ala Thr Phe Asp 
    50                  55                  60                  


Pro Val Asp Asn Ile Val Phe Asn Met Ala Ala Gly Ser Ala Pro Met 
65                  70                  75                  80  


Gln Leu His Leu Arg Ala Thr Ile Arg Met Lys Asp Gly Leu Cys Val 
                85                  90                  95      


Pro Arg Lys Trp Ile Tyr His Leu Thr Glu Gly Ser Thr Asp Leu Arg 
            100                 105                 110         


Thr Glu Gly Arg Pro Asp Met Lys Thr Glu Leu Phe Ser Ser Ser Cys 
        115                 120                 125             


Pro Gly Gly Ile Met Leu Asn Glu Thr Gly Gln Gly Tyr Gln Arg Phe 
    130                 135                 140                 


Leu Leu Tyr Asn Arg Ser Pro His Pro Pro Glu Lys Cys Val Glu Glu 
145                 150                 155                 160 


Phe Lys Ser Leu Thr Ser Cys Leu Asp Ser Lys Ala Phe Leu Leu Thr 
                165                 170                 175     


Pro Arg Asn Gln Glu Ala Cys Glu Leu Ser Asn Asn 
            180                 185             


<210>  2
<211>  190
<212>  PRT
<213>  Mus musculus

<400>  2

Met Phe His Gln Val Trp Ala Ala Leu Leu Ser Leu Tyr Gly Leu Leu 
1               5                   10                  15      


Phe Asn Ser Met Asn Gln Cys Pro Glu His Ser Gln Leu Thr Ala Leu 
            20                  25                  30          


Gly Met Asp Asp Thr Glu Thr Pro Glu Pro His Leu Gly Leu Trp Tyr 
        35                  40                  45              


Phe Ile Ala Gly Ala Ala Ser Thr Thr Glu Glu Leu Ala Thr Phe Asp 
    50                  55                  60                  


Pro Val Asp Asn Ile Val Phe Asn Met Ala Ala Gly Ser Ala Pro Arg 
65                  70                  75                  80  


Gln Leu Gln Leu Arg Ala Thr Ile Arg Thr Lys Ser Gly Val Cys Val 
                85                  90                  95      


Pro Arg Lys Trp Thr Tyr Arg Leu Thr Glu Gly Lys Gly Asn Met Glu 
            100                 105                 110         


Leu Arg Thr Glu Gly Arg Pro Asp Met Lys Thr Asp Leu Phe Ser Ser 
        115                 120                 125             


Ser Cys Pro Gly Gly Ile Met Leu Lys Glu Thr Gly Gln Gly Tyr Gln 
    130                 135                 140                 


Arg Phe Leu Leu Tyr Asn Arg Ser Pro His Pro Pro Glu Lys Cys Val 
145                 150                 155                 160 


Glu Glu Phe Gln Ser Leu Thr Ser Cys Leu Asp Phe Lys Ala Phe Leu 
                165                 170                 175     


Val Thr Pro Arg Asn Gln Glu Ala Cys Pro Leu Ser Ser Lys 
            180                 185                 190 


